1. Home
  2. HROW

HROW

Harrow Inc.

Logo Harrow Inc.

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

as 04-24-2024 4:00pm EST

$
-
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company helps U.S. eyecare professionals preserve the gift of sight by making its comprehensive portfolio of prescription and non-prescription pharmaceutical products accessible and affordable to millions of Americans.

Founded: 1998 Country:
United States
United States
Employees: N/A City: NASHVILLE
Market Cap: 369.5M IPO Year: N/A
Target Price: $31.50 AVG Volume (30 days): 455.6K
Analyst Decision: Strong Buy Number of Analysts: 2
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -0.75 EPS Growth: N/A
52 Week Low/High: $7.60 - $28.25 Next Earning Date: 05-09-2024
Revenue: $130,193,000 Revenue Growth: 46.95%
Revenue Growth (this year): 45.5% Revenue Growth (next year): 40.65%

Share on Social Networks: